MediVet Biologics relaunches as Ardent Animal Health

Under new ownership and leadership, the company reasserts its mission of providing affordable, innovative therapies for canine joint disease and cancer.

News wrap-up: Feline neutering, drug DISCO, rabies, and more

Top headlines of the week: State VMAs endorse Feline Fix by Five Months, rabies update, drug DISCO, and The Vet Blast Podcast with guest Steve Dale.

Drug DISCO: How commercial incentives can improve cancer drug development

A look at the One Health initiative that is stepping beyond science to generate more treatments more quickly for canine and human cancer.

Modulating the immune system to fight for good

Immunotherapy — using an individual’s own immune system to fight disease — is one of the fastest-growing areas in both human and veterinary research. Here’s the latest.

Toceranib: a weapon against apocrine gland anal sac tumors in dogs?

Apocrine gland anal sac adenocarcinoma is an aggressive cancer that might be better harnessed with targeted chemotherapeutic agents. A recent study evaluated the efficacy of toceranib in treating this tumor, and assessed prognostic factors.

Petco donates $250,000 to University of Wisconsin veterinary school

WeatherTech’s Super Bowl ad compels Petco’s CEO to help fund further cancer research at the school.